Applied Evidence

An FP’s guide to AI-enabled clinical decision support

Author and Disclosure Information

 

References

Addressing challenges, tapping resources

Advances in the management of diabetic retinopathy, colorectal cancer, and sepsis are the tip of the AI iceberg. There are now ML programs to distinguish melanoma from benign nevi; to improve insulin dosing for patients with type 1 diabetes; to predict which hospital patients are most likely to end up in the intensive care unit; and to mitigate the opioid epidemic.

An ML Web page on the JAMA Network (https://sites.jamanetwork.com/machine-learning/) features a long list of published research studies, reviews, and opinion papers suggesting that the future of medicine is closely tied to innovative developments in this area. This Web page also addresses the potential use of ML in detecting lymph node metastases in breast cancer, the need to temper AI with human intelligence, the role of AI in clinical decision support, and more.

The JAMA Network also discusses a few of the challenges that still need to be overcome in developing ML tools for clinical medicine—challenges that you will want to be cognizant of as you evaluate new research in the field.

Black-box dilemma. A challenge that technologists face as they introduce new programs that have the potential to improve diagnosis, treatment, and prognosis is a phenomenon called the “black-box dilemma,” which refers to the complex data science, advanced statistics, and mathematical equations that underpin ML algorithms. These complexities make it difficult to explain the mechanism of action upon which software is based, which, in turn, makes many clinicians skeptical about its worth.

A randomized clinical trial has found that an ML program that uses only 6 common clinical markers can improve clinical outcomes in patients with severe sepsis.

For example, the neural networks that are the backbone of the retinopathy algorithm discussed earlier might seem like voodoo science to those unfamiliar with the technology. It’s fortunate that several technology-savvy physicians have mastered these digital tools and have the teaching skills to explain them in plain-English tutorials. One such tutorial, “Understanding How Machine Learning Works,” is posted on the JAMA Network (https://sites.­jamanetwork.com/machine-learning/#multimedia). A more basic explanation was included in a recent Public Broadcasting System “Nova” episode, viewable at www.youtube.com/watch?v=xS2G0oolHpo.

Continue to: Limited analysis

Pages

Recommended Reading

USPSTF BRCA testing recs: 2 more groups require attention
MDedge Family Medicine
Panel releases guidelines for red meat, processed meat consumption
MDedge Family Medicine
Primary care for the declining cancer survivor
MDedge Family Medicine
How to overcome barriers to exercise for cancer patients
MDedge Family Medicine
Cancer overtakes CVD as cause of death in high-income countries
MDedge Family Medicine
USPSTF recommendations on risk assessment, genetic counseling, and genetic testing for BRCA-related cancer
MDedge Family Medicine
Disparity in endometrial cancer outcomes: What can we do?
MDedge Family Medicine
Levothyroxine dose for checkpoint inhibitor toxicity may be too high
MDedge Family Medicine
More evidence that statins reduce HCC risk
MDedge Family Medicine
ACP: Low-risk adults aged 50-75 should undergo regular screening for colorectal cancer
MDedge Family Medicine